MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · IEX Real-Time Price · USD
42.87
+1.85 (4.51%)
Apr 23, 2024, 3:54 PM EDT - Market open

MLTX Statistics

Total Valuation

MLTX has a market cap or net worth of $2.68 billion. The enterprise value is $2.11 billion.

Market Cap 2.68B
Enterprise Value 2.11B

Important Dates

The next estimated earnings date is Friday, May 10, 2024, before market open.

Earnings Date May 10, 2024
Ex-Dividend Date n/a

Share Statistics

MLTX has 62.45 million shares outstanding. The number of shares has increased by 67.30% in one year.

Shares Outstanding 62.45M
Shares Change (YoY) +67.30%
Shares Change (QoQ) -8.21%
Owned by Insiders (%) 9.42%
Owned by Institutions (%) 96.63%
Float 23.47M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 5.29
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 51.59, with a Debt / Equity ratio of 0.01.

Current Ratio 51.59
Quick Ratio 51.38
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -12.10% and return on invested capital (ROIC) is -10.84%.

Return on Equity (ROE) -12.10%
Return on Assets (ROA) -11.00%
Return on Capital (ROIC) -10.84%
Revenue Per Employee n/a
Profits Per Employee -$881,582
Employee Count 50
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, MLTX has paid $94,388 in taxes.

Income Tax 94,388
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +79.44% in the last 52 weeks. The beta is 1.19, so MLTX's price volatility has been higher than the market average.

Beta (1Y) 1.19
52-Week Price Change +79.44%
50-Day Moving Average 49.31
200-Day Moving Average 52.97
Relative Strength Index (RSI) 37.48
Average Volume (30 Days) 477,103

Short Selling Information

The latest short interest is 7.65 million, so 12.25% of the outstanding shares have been sold short.

Short Interest 7.65M
Short Previous Month 7.00M
Short % of Shares Out 12.25%
Short % of Float 32.61%
Short Ratio (days to cover) 12.23

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -54.12M
Pretax Income -43.98M
Net Income -44.08M
EBITDA -43.97M
EBIT -43.98M
Earnings Per Share (EPS) -$0.73
Full Income Statement

Balance Sheet

The company has $511.01 million in cash and $3.70 million in debt, giving a net cash position of $507.31 million or $8.12 per share.

Cash & Cash Equivalents 511.01M
Total Debt 3.70M
Net Cash 507.31M
Net Cash Per Share $8.12
Equity / Book Value 495.68M
Book Value Per Share 7.94
Working Capital 504.20M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$42.78 million and capital expenditures -$284,634, giving a free cash flow of -$43.06 million.

Operating Cash Flow -42.78M
Capital Expenditures -284,634
Free Cash Flow -43.06M
FCF Per Share -$0.88
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

MLTX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -67.30%
Shareholder Yield -67.30%
Earnings Yield -1.68%
FCF Yield -1.64%
Dividend Details

Analyst Forecast

The average price target for MLTX is $75.00, which is 74.95% higher than the current price. The consensus rating is "Strong Buy".

Price Target $75.00
Price Target Difference 74.95%
Analyst Consensus Strong Buy
Analyst Count 10
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2